13:45 24/05/2016 Stock Update (NASDAQ:AEZS): AEterna Zentaris Inc. (USA) Elects Ms. Carolyn ...
Stock Update (NASDAQ:AEZS): AEterna Zentaris Inc. (USA) Elects Ms. Carolyn ...
Smarter Analyst - May 24, 2016
AEterna Zentaris Inc. (USA) (NASDAQ:AEZS), a specialty biopharmaceutical company engaged in developing and commercializing novel treatments in oncology, endocrinology and women's health, today announced the separation of the positions of ...
AEterna Zentaris Names Carolyn Egbert as Independent Chair (NASDAQ:AEZS) - Sonoran Weekly Review
Eye Catching Stocks: Aeterna Zentaris (NASDAQ:AEZS), Aerie (NASDAQ:AERI), Rite ... - Benchmark Monitor

22:11 09/05/2016 Company Update (NASDAQ:AEZS): AEterna Zentaris Inc. (USA) Reports First ...
Company Update (NASDAQ:AEZS): AEterna Zentaris Inc. (USA) Reports First ...
Smarter Analyst - May 9, 2016
AEterna Zentaris Inc. (USA) (NASDAQ:AEZS), a specialty biopharmaceutical company engaged in developing and commercializing novel treatments in oncology, endocrinology and women's health, today reported financial and operating results for the first ...
AEterna Zentaris Inc. (AEZS) Receives "Buy" Rating from Maxim Group - NewsWay 21
AEterna Zentaris Inc. (AEZS) Rating Reiterated by Maxim Group - Web Breaking News

13:45 29/04/2016 Biotech Updates: Analysts Comment on AEterna Zentaris Inc. (USA) (AEZS), Keryx ...
Biotech Updates: Analysts Comment on AEterna Zentaris Inc. (USA) (AEZS), Keryx ...
Smarter Analyst - Apr 29, 2016
In a research issued yesterday, Maxim analyst Jason McCarthy reiterated a Buy rating on shares of AEterna Zentaris Inc. (USA) (NASDAQ:AEZS), with a price target of $11, after the biotech company announced the acquisition of “exclusive promotional ...

16:21 02/12/2015 Canaccord Weighs In On AEterna Zentaris Inc. (USA) (AEZS) Following Co ...
Canaccord Weighs In On AEterna Zentaris Inc. (USA) (AEZS) Following Co ...
Smarter Analyst - Dec 2, 2015
Canaccord's healthcare analyst Neil Maruoka weighed in on AEterna Zentaris Inc. (USA) (NASDAQ:AEZS), after the company announced the finalization of a co-promotion agreement with Armune BioScience for APIFINY, a test for prostate cancer.
Aeterna Zentaris Rises on Finalized Marketing Agreement - 24/7 Wall St.
Aeterna Zentaris Inc. (AEZS) Stock | Announces Co-Marketing Agreement with ... - Warrior Trading News (press release)

13:53 25/11/2015 Canaccord Adjusts Price Target For AEterna Zentaris Inc. (USA) (AEZS ...
Canaccord Adjusts Price Target For AEterna Zentaris Inc. (USA) (AEZS ...
Smarter Analyst - Nov 25, 2015
Canaccord analyst Neil Maruoka weighed in with a few insights on AEterna Zentaris Inc. (USA)(NASDAQ:AEZS), following the completion of share consolidation at a conversion ratio of 100-to-1, which became effective on November 20.
AEterna Zentaris Inc. (USA) (AEZS) Making Another Monster Move Today - Insider Monkey (blog)
Aeterna Zentaris (AEZS) Stock Surges On Exercise Of Stock Warrants - Bidness ETC

16:45 23/11/2015 Maxim Introduces New Price Target For AEterna Zentaris Inc. (USA) (AEZS) On ...
Maxim Introduces New Price Target For AEterna Zentaris Inc. (USA) (AEZS) On ...
Smarter Analyst - Nov 23, 2015
In a research report released today, Maxim analyst Jason Kolbert reiterated a Buy rating on shares of AEterna Zentaris Inc.

20:17 10/11/2015 Here's Why Canaccord Upgraded AEterna Zentaris Inc. (USA) (AEZS) to ...
Here's Why Canaccord Upgraded AEterna Zentaris Inc. (USA) (AEZS) to ...
Smarter Analyst - Nov 10, 2015
In a research report published yesterday, Canaccord analyst Neil Maruoka upgraded shares of AEterna Zentaris Inc. (USA) (NASDAQ:AEZS) from a Hold to a Speculative Buy rating, while reducing the price target to $0.10 (from $0.15), which represents a ...
UPDATE: Canaccord Genuity Upgrades AEterna Zentaris (AEZS) to Spec. Buy ... - StreetInsider.com

21:22 06/11/2015 Maxim Reiterates Buy on AEterna Zentaris Inc. (USA) Following 3Q Update
Maxim Reiterates Buy on AEterna Zentaris Inc. (USA) Following 3Q Update
Smarter Analyst - Nov 6, 2015
In a research report published Friday, Maxim Group analyst Jason Kolbert reiterated a Buy rating on shares of AEterna Zentaris Inc. (USA) (NASDAQ:AEZS) with a $2.00 price target, following the company's third-quarter financial results and update on its ...

16:57 13/10/2015 Maxim Weighs In On AEterna Zentaris Inc. (USA) (AEZS) As The DSMB Recommends ...
Maxim Weighs In On AEterna Zentaris Inc. (USA) (AEZS) As The DSMB Recommends ...
Smarter Analyst - Oct 13, 2015
Maxim Group analyst Jason Kolbert came out today with a few insights on AEterna Zentaris Inc. (USA)(NASDAQ:AEZS), after the company announced that the independent Data and Safety Monitoring Board (DSMB) gave the approval to continue the pivotal ...
Aeterna Zentaris: Data and Safety Monitoring Board Recommends Continuation of ... - PR Newswire (press release)
Aeterna Zentaris (AEZS) Announces DSMB Recommendation to Continue Phase 3 ... - StreetInsider.com

20:47 28/09/2015 Maxim Weighs In On AEterna Zentaris Inc. (USA) Following Positive Clinical ...
Maxim Weighs In On AEterna Zentaris Inc. (USA) Following Positive Clinical ...
Smarter Analyst - Sep 28, 2015
In a research report issued today, Maxim analyst Jason Kolbert reiterated a Buy rating on shares of AEterna Zentaris Inc. (USA) (NASDAQ:AEZS) with a $2 price target, after the company announced that its lead oncology compound, zoptarelin doxorubicin ...
AEterna Zentaris Inc. (USA)(NASDAQ:AEZS) Gets TSX Approval of Series 'B ... - Journal Transcript
Aeterna Zentaris' Zoptarelin Doxorubicin Meets Phase 2 Primary Endpoint in Men ... - PR Newswire (press release)